Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.6.520

Diphlorethohydroxycarmalol, Isolated from Ishige okamurae, Increases Prostaglandin E2 through the Expression of Cyclooxygenase-1 and -2 in HaCaT Human Keratinocytes  

Kang, Gyeoung-Jin (Department of Pharmacology, Jeju National University)
Han, Sang-Chul (Department of Pharmacology, Jeju National University)
Koh, Young-Sang (Department of Microbiology, School of Medicine, Jeju National University)
Kang, Hee-Kyoung (Department of Pharmacology, Jeju National University)
Jeon, You-Jin (Aqua GreenTechnology Co., Jeju Bio-Industry Center)
Yoo, Eun-Sook (Department of Pharmacology, Jeju National University)
Publication Information
Biomolecules & Therapeutics / v.20, no.6, 2012 , pp. 520-525 More about this Journal
Abstract
Prostaglandin (PG) $E_2$, the most abundant prostaglandin in the human body, is synthesized from arachidonic acid via the actions of cyclooxygenase (COX) enzymes. $PGE_2$ exerts homeostatic, cytoprotective, inflammatory, and in some cases anti-inflammatory effects. Also, it has been reported that $PGE_2$ is involved in hair growth. Diphlorethohydroxycarmalol (DPHC) is a phlorotannin compound isolated from the brown algae Ishige okamurae, with various biological activities in vitro and in vivo. In this study, the biological effect and mechanism of action of DPHC on prostaglandin synthesis in HaCaT human keratinocytes was examined. The results showed that, in these cells, DPHC significantly and dose-dependently induced $PGE_2$ synthesis by increasing the protein and mRNA levels of COX-1 and COX-2. Interestingly, DPHC-induced COX-1 expression preceded that of COX-2. Also, while both rofecoxib and indomethacin inhibited $PGE_2$ production, the latter was seems to be the more potent. From above results, we can expect that DPHC has some beneficial effects via increasing of $PGE_2$ production.
Keywords
Diphlorethohydroxycarmalol; Cyclooxygenases; Prostaglandin $E_2$; HaCaT keratinocytes;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ahn, M., Moon, C., Yang, W., Ko, E. J., Hyun, J. W., Joo, H. G., Jee, Y., Lee, N. H., Park, J. W., Ko, R. K., Kim, G. O. and Shin, T. (2011) Diphlorethohydroxycarmalol, isolated from the brown algae Ishige okamurae, protects against radiation-induced cell damage in mice. Food Chem. Toxicol. 49, 864-870.   DOI
2 Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B. and Lipsky, P. E. (1998) Cyclooxygenase in biology and disease. FASEB J. 12, 1063-1073.
3 Flower, R. J. (2006) Prostaglandins, bioassay and inflammation. Br. J. Pharmacol. 147 Suppl 1, S182-192.
4 Giuliano, F. and Warner, T. D. (2002) Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J. Pharmacol. Exp. Ther. 303, 1001-1006.   DOI   ScienceOn
5 Hamaoka, H., Minakuchi, K., Miyoshi, H., Arase, S., Chen, C. H. and Nakaya, Y. (1997) Effect of $K^+$ channel openers on $K^+$ channel in cultured human dermal papilla cells. J. Med. Invest. 44, 73-77.
6 Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P. (2002) Prostaglandins as modulators of immunity. Trends Immunol. 23, 144-150.   DOI   ScienceOn
7 Heo, S. J., Hwang, J. Y., Choi, J. I., Han, J. S., Kim, H. J. and Jeon, Y. J. (2009) Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent alpha-glucosidase and alpha-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 615, 252-256.   DOI
8 Heo, S. J., Kim, J. P., Jung, W. K., Lee, N. H., Kang, H. S., Jun, E. M., Park, S. H., Kang, S. M., Lee, Y. J., Park, P. J. and Jeon, Y. J. (2008) Identification of chemical structure and free radical scavenging activity of diphlorethohydroxycarmalol isolated from a brown alga, Ishige okamurae. J. Microbiol. Biotechnol. 18, 676-681.   과학기술학회마을
9 Heo, S. J., Ko, S. C., Kang, S. M., Cha, S. H., Lee, S. H., Kang, D. H., Jung, W. K., Affan, A., Oh, C. and Jeon, Y. J. (2010) Inhibitory effect of diphlorethohydroxycarmalol on melanogenesis and its protective effect against UV-B radiation-induced cell damage. Food Chem. Toxicol. 48, 1355-1361.   DOI
10 Hoggaat, J., Singh, P., Sampath, J. and Pelus, L. M. (2009) Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113, 5444-5455.   DOI
11 Johnstone, M. A. and Albert, D. M. (2002) Prostaglandin-induced hair growth. Surv. Ophthalmol. 47 Supple 1, S185-202   DOI
12 Kim, M. M., Rajapakse, N. and Kim, S. K. (2009) Anti-inflammatory effect of Ishige okamurae ethanolic extract via inhibition of NF-kappaB transcription factor in RAW 264.7 cells. Phytother. Res. 23, 628-634.   DOI
13 Lachgar, S., Charveron, M., Gall, Y. and Bonafe, J. L. (1998) Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br. J. Dermatol. 138, 407-411.   DOI   ScienceOn
14 Langenbach, R., Loftin, C., Lee, C. and Tiano, H. (1999) Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem. Pharmacol. 58, 1237-1246.   DOI
15 Maldve, R. E., Kim, Y., Muga, S. J. and Fischer, S. M. (2000) Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J. Lipid Res. 41, 873-881.
16 Shorter, K., Farjo, N. P., Picksley, S. M. and Randall, V. A. (2008) Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J. 22, 1725-1736.   DOI   ScienceOn
17 Michelet, J. F., Commo, S., Billoni, N., Mahé, Y. F. and Bernard, B. A. (1997) Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J. Invest. Dermatol. 108, 205-209.   DOI
18 Ricciotti, E. and FitzGerald, G. A. (2011) Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 986-1000.   DOI
19 Sasaki, S., Hozumi, Y. and Kondo, S. (2005) Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp. Dermatol. 14, 323-328.   DOI
20 Tai, H. H., Chi, X. and Tong, M. (2011) Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). Prostaglandins Other Lipid Mediat. 96, 37-40.   DOI   ScienceOn
21 Tai, H. H., Cho, H., Tong, M. and Ding, Y. (2006) NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr. Pharm. Des. 12, 955-962.   DOI
22 Tanabe, T. and Tohnai, N. (2002) Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat. 68-69, 95-114.   DOI
23 Vane, J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231, 232-235.   DOI
24 Warner, T. D. and Mitchell, J. A. (2004) Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18, 790-804.   DOI   ScienceOn